ACP journal club. Review: β-blockers do not reduce mortality in myocardial infarction in the reperfusion era

Comment

. 2015 Mar 17;162(6):JC3.

doi: 10.7326/ACPJC-2015-162-6-003.

Comment

Steven Borzak. Ann Intern Med. 2015.

. 2015 Mar 17;162(6):JC3.

doi: 10.7326/ACPJC-2015-162-6-003.

No abstract available

Comment on

Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.
Bangalore S, Makani H, Radford M, Thakur K, Toklu B, Katz SD, DiNicolantonio JJ, Devereaux PJ, Alexander KP, Wetterslev J, Messerli FH. Bangalore S, et al. Am J Med. 2014 Oct;127(10):939-53. doi: 10.1016/j.amjmed.2014.05.032. Epub 2014 Jun 11. Am J Med. 2014. PMID: 24927909

Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.
Bangalore S, Makani H, Radford M, Thakur K, Toklu B, Katz SD, DiNicolantonio JJ, Devereaux PJ, Alexander KP, Wetterslev J, Messerli FH. Bangalore S, et al. Am J Med. 2014 Oct;127(10):939-53. doi: 10.1016/j.amjmed.2014.05.032. Epub 2014 Jun 11. Am J Med. 2014. PMID: 24927909
Clinical outcomes with beta-blockers after myocardial infarction: finding the right patient and the right regimen.
Jennings DL, Miyares MA. Jennings DL, et al. Am J Med. 2014 Dec;127(12):e17. doi: 10.1016/j.amjmed.2014.07.038. Am J Med. 2014. PMID: 25481200 No abstract available.
The reply.
Bangalore S, Messerli FH. Bangalore S, et al. Am J Med. 2014 Dec;127(12):e19. doi: 10.1016/j.amjmed.2014.08.011. Am J Med. 2014. PMID: 25481201 No abstract available.
Cardioprotection: Where to from here?
Kloner RA, Hale SL, Dai W, Shi J. Kloner RA, et al. Cardiovasc Drugs Ther. 2017 Feb;31(1):53-61. doi: 10.1007/s10557-016-6691-0. Cardiovasc Drugs Ther. 2017. PMID: 27714476 Review.
[Secondary prophylaxis with beta blockers after myocardial infarction].
Bosković D. Bosković D. Srp Arh Celok Lek. 1992 Jun;120 Suppl 4:25-34. Srp Arh Celok Lek. 1992. PMID: 18193807 Review. Serbian.